Global Biopharm Regulations was founded in 2000. The focus of the practice is to serve the biopharmaceutical regulated industry. We specialize in regulatory affairs consulting and quality compliance and oversight. We also provide services for over-the-counter (OTC) medications and other neutraceuticals. Our goal is to develop long-term relationships by providing comprehensive drug development strategies to accelerate time to approval.

Key Milestones

• 2000 Registered with Secretary of State
• October 2002 Completed First Government Assignment for NIH-NIAID
• Nov 2003 Grew to 3 employee
• June 2006 Self Certified as a Small Business
• January 2007 Grew to 11 employees
• April 2007 Certified as Small Disadvantaged Business (SDB)
• March 2008 Completed Second Government Assignment -NIH-NIAID and NCI
• March 2009 Applied to qualify for SBA 8(a) status
• March 2009 Completed a project with NIH NIH-NIAID
• May 2010 Obtained 8(a) approval
• June 2010 Completed a project for Novartis Vaccine and Diagnostics
• Sept 2011 Completed a project for Dr. Reddys Laboratory
• April 2012 Obtained California Small Disadvantaged certification

• Orange County Regulatory Discussion Group
  Ruchika Raval is one of the Board of Directors for OCRA.
• American Society for Quality (ASQ)
  Ruchika Raval is Vice Chair for Programs at the San Gabriel Valley Chapter for ASQ.
• Parenteral Drug Association (PDA)
  Ruchika Raval serves on the board of directors of the Southern California chapter of PDA.
• Small Business Administration (SBA)
  The SBA has approved Global Biopharm Regulations as a Small Disadvantaged Business under the 8(a) program.
• Small Disadvantaged Business (CA)
  Global Biopharm Regulations has been selected as a SDB this April 2012.
• Women's Business Enterprise National Council
  Global Biopharm Regulations as applied to be recognized as a WBENC firm.
• Minority Supplier Development Council
  Global Biopharm Regulations is a member.